The role of cytokines in chronic rhinosinusitis with nasal polyps

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 16, Issue 3, 2008, Pages 270-274

  Otto, Bradley A ^a   Wenzel, Sally E ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Chronic sinusitis; Cytokine; Inflammation; Nasal polyps

Indexed keywords

CYTOKINE; ENTEROTOXIN; ENTEROTOXIN B; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 4; INTERLEUKIN 5; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

CELL INFILTRATION; DISEASE ASSOCIATION; DOWN REGULATION; FIBROBLAST; GENE FUNCTION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; NOSE POLYP; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; RHINOSINUSITIS; SINGLE NUCLEOTIDE POLYMORPHISM; STAPHYLOCOCCUS EPIDERMIDIS; UPREGULATION;

CHRONIC DISEASE; CYTOKINES; HUMANS; NASAL POLYPS; RHINITIS; SINUSITIS;

EID: 43549098590     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e3282fb2885     Document Type: Review

References (34)

1. Bachert C, Gevaert P, Holtappels G, et al. Nasal polyposis: from cytokines to growth. Am J Rhinol 2000; 14:279-290.
2. Liu Z, Lu X, Wang H, et al. The up-regulated expression of tenascin C in human nasal polyp tissues is related to eosinophil-derived transforming growth factor beta1. Am J Rhinol 2006; 20:629-633.
3. Van Zele T, Claeys S, Gevaert P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 2006; 61:1280-1289.
4. Figueiredo CR, Santos RP, Silva ID, et al. Microarray cDNA to identify inflammatory genes in nasal polyposis. Am J Rhinol 2007; 21:231-235. This article identifies several cytokine genes that are increased in adjacent inflammatory mucosa versus nasal polyp tissue with special attention to TGF-β.
5. Scavuzzo MC, Fattori B, Ruffoli R, et al. Inflammatory mediators and eosinophilia in atopic and nonatopic patients with nasal polyposis. Biomed Pharmacother 2005; 59:323-329.
6. Schroder K, Hertzog PJ, Ravasi T, et al. Interferon-: an overview of signals, mechanisms and functions. J Leukoc Biol 2004.
7. Nakajima H, Takatsu K. Role of cytokines in allergic airway inflammation. Int Arch Allergy Immunol 2007; 142:265-273.
8. Danielsen A, Tynning T, Brokstad KA, et al. Interleukin 5, IL6, IL12, IFN-gamma, RANTES and Fractalkine in human nasal polyps, turbinate mucosa and serum. Eur Arch Ortorhinolaryngol 2006; 263:282-289.
9. h1 cells does not.
10. Bernstein JM, Ballow M, Rich G, et al. Lymphocyte subpopulations and cytokines in nasal polyps: is there a local immune system in the nasal polyp? Ortolaryngol Head Neck Surg 2004; 130:526-535.
11. Chen YS, Arab SF, Westhofen M, et al. Expression of interleukin-5, interleukin-8, and interleukin-10 mRNA in the osteomeatal complex in nasal polyposis. Am J Rhinol 2005.
12. Kostamo K, Sorsa T, Leino M, et al. In vivo relationship between collagenase-2 and interleukin-8 but not tumour necrosis factor-alpha in chronic rhinosinusitis with nasal polyposis. Allergy 2005; 60:1275-1279.
13. Bradley DT, Kountakis SE. Role of interleukins and transforming growth factor-beta in chronic rhinosinusitis and nasal polyposis. Laryngoscope 2005; 115:684-686.
14. Rudack C, Steinhoff M, Mooren F, et al. PAR-2 activation regulates IL-8 and GRO-alpha synthesis by NF-kappaB, but not RANTES, IL-6, eotaxin or TARC expression in nasal epithelium. Clin Exp Allergy 2007; 37:1009-1022. This article investigates the effect of PAR-2 stimulation on the release of pro-inflammatory cytokines and the signaling mechanisms involved. The aticle demonstrates increased PAR-2 expression in CRSsNP, CRSwNP and acute rhinosinusitis specimens versus controls and demonstrates active PAR in primary nasal epithelial cell culture. PAR-2 agonists increase IL-8 and GRO-α expression in vitro.
15. Sachse F, von Eiff C, Becker K, et al. Proinflammatory impact of Staphylococcus epidermidis on the nasal epithelium quantified by IL-8 and GRO-alpha responses in primary human nasal epithelial cells. Int Arch Allergy Immunol 2007; 145:24-32. This article investigates the effect of S. epidermidis on the release of proinflammatory cytokines from sinonasal epithelial cells.
16. Nouri-Aria KT, Irani AM, Jacobson MR, et al. Basophil recruitment and IL-4 production during human allergen-induced late asthma. J Allergy Clin Immunol 2001; 108:205-211.
17. Nonaka M, Fukumoto A, Ogihara N, et al. Expression of MCP-4 by TLR ligand-stimulated nasal polyp fibroblasts. Acta Otolaryngol 2007:1-6. This article investigates the synergistic effect of IL-4 and TLR ligands on the release of the eosinophil chemotactic factor MCP-4 in vitro. TLR 2, 3, 4 and 5 ligands synergize with IL-4 to induce the production of MCP-4.
18. Yea SS, Yang YI, Park SK, et al. Interleukin-4 C-590T polymorphism is associated with protection against nasal polyps in a Korean population. Am J Rhinol 2006; 20:550-553.
19. Petecchia L, Serpero L, Silvestri M, et al. The histamine-induced enhanced expression of vascular cell adhesion molecule-1 by nasal polyp-derived fibroblasts is inhibited by levocetirizine. Am J Rhinol 2006; 20:445-449.
20. Fukumoto A, Nonaka M, Ogihara N, et al. Induction of TARC production by lipopolysaccharide and interleukin-4 in nasal fibroblasts. Int Arch Allergy Immunol 2007; 145:291-297. This article demonstrates the synergistic effect of IL-4 on LPS-induced TARC expression in nasal fibroblasts.
21. Fan GK, Wang H, Takenaka H. Eosinophil infiltration and activation in nasal polyposis. Acta Oto-Laryngologica 2007.
22. Chen YS, Langhammer T, Westhofen M, et al. Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps. Allergy 2007; 62:66-72.
23. Chen Y, A.S., Westhofen M, Lorenzen J, Expression of Interleukin-5, Interleukin-8, andInterleukin-10 mRNA in the Osteomeatal Complex in Nasal Polyposis. Am J Rhinol 2005.
24. Bachert C, Wagenmann M, Hauser U, et al. IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol 1997; 99 (6 Pt 1):837-842.
25. h2 cytokine profile in stimulated nasal polyp tissue.
26. Coste A, Lefaucheur JP, Wang QP, et al. Expression of the transforming growth factor beta isoforms in inflammatory cells of nasal polyps. Arch Otolaryngol Head Neck Surg 1998; 124:1361-1366.
27. Little SC, Early SB, Woodard CR, et al. Dual action of TGF-beta1 on nasal-polyp derived fibroblasts. Laryngoscope 2007. This article identifies increased in-vitro fibroblast proliferation rate in nasal polyps versus control after TGF-β1 stimulation. The anti-inflammatory and pro-fibrotic effects on nasal polyp-derived fibroblasts stimulated with TGF-β1 are also investigated.
28. Watelet JB, Claeys C, Perez-Novo C, et al. Transforming growth factor beta1 in nasal remodeling: differences between chronic rhinosinusitis and nasal polyposis. Am J Rhinol 2004; 18:267-272.
29. Serpero L, Petecchia L, Sabatini F, et al. The effect of transforming growth factor (TGF)-beta1 and (TGF)-beta2 on nasal polyp fibroblast activities involved upper airway remodeling: modulation by fluticasone propionate. Immunol Lett 2006; 105:61-67.
30. Chu HW, Balzar S, Seedorf GJ, et al. Transforming growth factor-beta2 induces bronchial epithelial mucin expression in asthma. Am J Pathol 2004; 165:1097-1106.
31. Alam R, Forsythe P, Stafford S, et al. Transforming growth factor beta abrogates the effects of hematopoietins on eosinophils and induces their apoptosis. J Exp Med 1994; 179:1041-1045.
32. Steinke JW, Crouse CD, Bradley D, et al. Characterization of interleukin-4-stimulated nasal polyp fibroblasts. Am J Respir Cell Mol Biol 2004; 30:212-219.
33. Erbek SS, Yurtcu E, Erbek S, et al. Proinflammatory cytokine single nucleotide polymorphisms in nasal polyposis. Arch Otolaryngol Head Neck Surg 2007; 133:705-709.
34. Lin SK, Kok SH, Shun CT, et al. Tumor necrosis factor-alpha stimulates the expression of C-C chemokine ligand 2 gene in fibroblasts from the human nasal polyp through the pathways of mitogen-activated protein kinase. Am J Rhinol 2007; 21:251-255. This article identifies a signaling pathway involved in the TNF-α mediated release of CCL2 from nasal polyp fibroblasts. B-Raf/MEK/ERK signaling cascade is responsible for c-Fos activation and the subsequent AP-1/DNA interaction leading to CCL2 expression.